Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases
- PMID: 12707574
- DOI: 10.1097/00002281-200305000-00008
Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases
Abstract
This article examines immunosuppressant transplant agents used to treat the various rheumatic diseases. The older drugs of this type have been used in this dual role for decades. There is a new generation of immunosuppressant drugs with established use in the arena of transplantation medicine. Only recently have the potential rheumatologic applications for these agents been investigated. The authors review in depth the published experience with the newer agents. The authors also discuss novel rheumatologic uses for the older agents that have been described within the past year.
Similar articles
-
New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.Clin Dermatol. 2002 Sep-Oct;20(5):505-14. doi: 10.1016/s0738-081x(02)00271-7. Clin Dermatol. 2002. PMID: 12435521 Review. No abstract available.
-
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.Circulation. 2004 Dec 21;110(25):3858-65. doi: 10.1161/01.CIR.0000150332.42276.69. Circulation. 2004. PMID: 15611389 Review. No abstract available.
-
Mycophenolate mofetil in pancreas transplantation.Transplantation. 1998 Aug 15;66(3):318-23. doi: 10.1097/00007890-199808150-00007. Transplantation. 1998. PMID: 9721799
-
Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.Exp Clin Transplant. 2011 Oct;9(5):295-301. Exp Clin Transplant. 2011. PMID: 21967254 Clinical Trial.
-
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients.Transplantation. 2012 Sep 15;94(5):450-5. doi: 10.1097/TP.0b013e318264351e. Transplantation. 2012. PMID: 22960763
Cited by
-
Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus.Mol Biol Rep. 2023 Apr;50(4):3815-3833. doi: 10.1007/s11033-023-08283-x. Epub 2023 Jan 25. Mol Biol Rep. 2023. PMID: 36696023 Free PMC article. Review.
-
Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):372-385. doi: 10.1167/iovs.16-19159. Invest Ophthalmol Vis Sci. 2017. PMID: 28122086 Free PMC article.
-
A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.J Control Release. 2013 Nov 10;171(3):269-79. doi: 10.1016/j.jconrel.2013.07.016. Epub 2013 Jul 25. J Control Release. 2013. PMID: 23892265 Free PMC article.
-
Low dose rapamycin exacerbates autoimmune experimental uveitis.PLoS One. 2012;7(5):e36589. doi: 10.1371/journal.pone.0036589. Epub 2012 May 4. PLoS One. 2012. PMID: 22574188 Free PMC article.
-
Restoring the infected powerhouse: Mitochondrial quality control in sepsis.Redox Biol. 2023 Dec;68:102968. doi: 10.1016/j.redox.2023.102968. Epub 2023 Nov 23. Redox Biol. 2023. PMID: 38039825 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous